Overview

Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of first-line treatment with a free combination (as two separate pills) of nebivolol and lisinopril in patients with stage 2 diastolic hypertension (DBP>= 100 mmHg).

Phase:

Phase 4

Details

Lead Sponsor:

Forest Laboratories

Treatments:

Lisinopril
Nebivolol